Life Science Practice Success

Larta Institute is proud of its performance on behalf of Life Science innovations.

 These are some of the results of our dedicated life science practice over the past four years:

• 39 companies have been able to raise over $68M in funding
• 1,414 contacts with investors
• 1,143 meetings with investors and partners
• 558 CDA’s (Confidentiality Disclosure Agreements) signed
• 302 Negotiations with investors and partners
• 138 initial proposals and term sheets
• 109 deals
• 91% of companies cite that the our programs have made a valuable or major impact in getting their product into the marketplace
• 97% of companies indicated that they would recommend our programs to others

 What Innovators Are Saying…

 “The understanding of the investor mentality which I received… (from the program) formed the basis for presentations made and business plans written.  This ultimately resulted in (a) $2.6 M investment. We would not have obtained the investment without the attitude adjustment provided by (the program.) (It) pointed me in the right direction and gave me the initial tools to speak the right language with investors.”

 IA, Inc/Threefold Sensors
Raised $2.6 million from strategic investors.



“(The program) provided a valuable platform for new technology presentation, business networking and investment opportunities.  Vivo represents a success story of the SBIR program i.e. development and commercialization of novel biotechnology products through an active R&D program and VC funding.”

Vivo Biosciences
Finalized first round $2 million investment deal
Secured 2 service contracts for cancer drug testing and discovery
Agreement to develop new preclinical bioassay systems and test drug candidates



“It takes time to build up momentum and credibility with potential strategic partners.  Our efforts have finally paid off, and I believe that we will sign 1 or 2 major agreements within the next 30-60 days.  The lessons learned in (the program) gave us a foundation that we could build upon.  Even though there may no longer be a direct influence in day to day activities, the general knowledge learned got us started and is still very important in helping us to continue to make progress.”

Zycare, Inc.
Due diligence begun with 2 potential strategic partners
Company expects revenue to increase at least 10 fold this year
Raised $750K in angel funding in May 2007